Zheng Zhongwei, director of the Science and Technology Development Center of the National Health and Health Commission of China and the leader of the working group of the vaccine research and development special class, said on Wednesday (December 7) that the current leaders of the party and the country have inoculated the coronary virus vaccine and vaccinatedAll are the same domestic vaccine as ordinary people.
According to the First Financial Report, Zheng Zhongwei introduced at a press conference held by the China State Council's joint prevention and control mechanism that China's coronary virus vaccine was very safe, and the benefit after vaccination was far greater than risks.The China Centers for Disease Control and Prevention has a adverse reaction monitoring of more than 3.4 billion doses and more than 1.3 billion people in China that has been vaccinated in China.The incidence of reaction is still slightly lower than young people.
Zheng Zhongwei said that China has provided more than 2.2 billion doses of vaccines to more than 120 countries and international organizations around the world.It can also be seen from the report that the heads of state, the head of the government, and the government officials of more than 30 countries took the lead in vaccination in China.So far, according to China's incomplete statistics, the elderly over 60 years of age have been vaccinated by more than 1 billion doses, which are very safe.
Zheng Zhongwei said, "Here, I can tell you that the party and the state leaders have vaccinated the new crown virus vaccine, and the vaccination is the same domestic new crown virus vaccine as ordinary people."
Zheng Zhongwei once again emphasized that for the elderly, as long as the conditions are met, it is necessary to speed up the vaccine vaccine vaccine to achieve exhaustion. Only in this way can we better protect their physical health andlife safety.
China released a new 10 optimized epidemic prevention on Wednesday, one of which is clear, and accelerate the vaccination of the elderly's coronary virus vaccine.All localities should adhere to the principles of connection, focus on increasing the vaccination rate of people aged 60 to 79, accelerate and increase the vaccination rate of people 80 and over, and make special arrangements.
The Chinese State Council formulated a full vaccination rate and enhanced needle vaccination rate of crown disease vaccine over 60 years of age and over 60 years of age of new crown virus vaccine vaccination work on November 29.
There are four domestic coronary vaccines in China for emergency approval within two days.At present, 13 Chinese domestic crown diseases have been approved, and they have covered analogy vaccine, restructuring protein vaccine, virus carrier vaccine, etc., involving Chinese biology, Kexing Zhongwei, Kangshino, etc.The global vaccine technology route accounts for a relatively high MRNA coronary vaccine. At present, there is no approval of local Chinese companies. However, at least ten companies such as Chinese Medicine Fusen Jian and Stone Medicine Group are developing.
